News Overview

Hero MotoCorp has appointed Reema Jain as the new Chief Information Digital Officer to lead the technology driven business transformation She will further strengthen the companys initiatives such as IT-related infrastructure strategic planning aligning digital strategies including the usage of new-age technologies Jain will directly report to Dr Pawan Munjal Chairman and CEO Hero MotoCorp

NMDC achieved iron ore production of 431 million ton in month of February 2022 compared to 386 million ton in February 2021 The company achieved sales of 397 million ton in February 2022 compared to 325 million ton in February 2021

KCL Infra Projects announced that the meeting of the Board of Directors of the Company is scheduled to be held on 07 March 2022 inter alia to consider and decide fund raising by way of rights issue of equity shares of the Company and for matters incidental thereto

Akshar Spintex will hold a meeting of the Board of Directors of the Company on 9 March 2022

Aditya Birla Fashion Retail has allotted 110808 equity shares on 02 March 2022 under ESOP Consequently the paid up equity share capital has increased to Rs 93829 crore

Tube Investments of India has allotted 44184 equity shares under ESOP With this allotment the paid up equity share capital has increased from Rs 192906037 to Rs 192950221

TVS Motor Company announced the launch of the feature-rich offering in the 125cc segment TVS Raider for the aspirational young customers across countries in Latin America LATAM The distinctly young and sporty motorcycle comes with first-in-class features such as an LCD digital speedometer 3V i-Touch Start animalistic LED headlamp and first-in-segment under-seat storage The new generation bike has been launched for Gen Z customers in […]

Hindalco Industries announced the resignation of Debnarayan Bhattacharya DIN 00033553 Non – Executive Director of the Company with effect from 02 March 2022

Panacea Biotec announced that the asset purchase agreement has been executed on 28 February 2022 for the sale of pharmaceutical formulation brands of the companys material subsidiary Panacea Biotech Pharma in India and Nepal to Mankind Pharma for an aggregate consideration of Rs 1827 crore

Vedanta announced that the Board of Directors of the Company at its meeting held on 2 March 2022 inter alia have recommended the Third Interim dividend of Rs 13 per equity Share ie 1300Percentage subject to the approval of the shareholders